Korro Bio, Inc.
KRRO
$20.15
$0.0750.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.28M | 4.82M | 2.27M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.28M | 4.82M | 2.27M | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.28M | 4.82M | 2.27M | -- | -- |
| SG&A Expenses | 42.30M | 41.84M | 41.87M | 45.08M | 42.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 104.84M | 100.30M | 94.18M | 95.76M | 91.62M |
| Operating Income | -98.55M | -95.48M | -91.91M | -95.76M | -91.62M |
| Income Before Tax | -91.26M | -87.29M | -83.44M | -87.77M | -85.25M |
| Income Tax Expenses | 95.00K | 124.00K | 141.00K | 38.00K | 47.00K |
| Earnings from Continuing Operations | -91.36 | -87.41 | -83.58 | -87.81 | -85.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -91.36M | -87.41M | -83.58M | -87.81M | -85.30M |
| EBIT | -98.55M | -95.48M | -91.91M | -95.76M | -91.62M |
| EBITDA | -93.98M | -91.41M | -88.35M | -92.47M | -88.27M |
| EPS Basic | -9.76 | -9.44 | -9.39 | -11.94 | -74.76 |
| Normalized Basic EPS | -6.09 | -5.89 | -5.86 | -7.46 | -46.72 |
| EPS Diluted | -9.76 | -9.44 | -9.39 | -11.94 | -74.76 |
| Normalized Diluted EPS | -6.09 | -5.89 | -5.86 | -7.46 | -46.72 |
| Average Basic Shares Outstanding | 37.45M | 37.04M | 35.68M | 31.59M | 22.58M |
| Average Diluted Shares Outstanding | 37.45M | 37.04M | 35.68M | 31.59M | 22.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |